한글목차

심장재동기화치료(CRT) 기기 시장 규모는 2025년 55억 3,000만 달러에서 2034년에는 89억 3,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 5.47%로 성장할 전망입니다.

세계 심장재동기화치료(CRT) 기기 시장은 심부전 유병률 증가와 첨단 치료 옵션에 대한 인식이 높아짐에 따라 큰 폭의 성장이 예상됩니다. 심박조율기 및 이식형 제세동기(ICD)를 포함한 CRT 기기는 심부전 환자의 심장 리듬과 기능을 개선하기 위해 고안되었습니다. 의료 서비스 제공자들이 심장 질환을 관리할 수 있는 효과적인 솔루션을 찾고 있는 가운데 CRT 기기의 채택이 크게 증가하여 이 중요한 시장에서 혁신과 투자를 촉진할 것으로 예상됩니다.

또한, CRT 기술의 발전과 기기 설계의 혁신은 시장의 성장을 더욱 촉진할 것으로 예상됩니다. 원격 모니터링 기능, 배터리 수명 향상 등 강화된 기능을 갖춘 차세대 CRT 기기 개발은 환자의 치료 결과와 편의성 향상에 기여하고 있습니다. 또한, 맞춤형 의료와 환자 중심 치료에 대한 관심이 높아지면서 환자 개개인의 필요에 따라 조정 가능한 CRT 기기에 대한 수요가 증가하고 있습니다. 의료 환경이 계속 진화하는 가운데, 심장재동기화치료 기기 시장에서는 환자 치료와 삶의 질을 향상시키는 혁신적인 솔루션에 대한 수요가 급증할 것으로 예상됩니다.

또한, 규제 준수와 임상적 근거에 대한 관심이 높아지는 것도 CRT 기기 시장의 미래를 형성하는 요인이 될 것입니다. 규제 당국이 기기 승인 및 모니터링에 대한 보다 엄격한 가이드라인을 시행함에 따라, 이러한 기준을 충족하는 CRT 기기에 대한 수요는 계속 증가할 것으로 예상됩니다. 기기 제조업체, 의료 서비스 제공자, 규제 당국 간의 협력적 노력은 이러한 발전을 촉진하고 심장재동기화치료 기기 시장이 심혈관 분야 혁신의 최전선에 서는 데 필수적입니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 심장재동기화치료 기기 시장 : 제품별

제5장 세계의 심장재동기화치료 기기 시장 : 최종사용별

제6장 세계의 심장재동기화치료 기기 시장 : 지역별

제7장 경쟁 구도

제8장 기업 개요

영문목차

The Cardiac Resynchronization Therapy Devices Market size is expected to reach USD 8.93 Billion in 2034 from USD 5.53 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.

The global cardiac resynchronization therapy (CRT) devices market is poised for significant growth, driven by the increasing prevalence of heart failure and the growing awareness of advanced treatment options. CRT devices, which include pacemakers and implantable cardioverter-defibrillators, are designed to improve the heart's rhythm and function in patients with heart failure. As healthcare providers seek effective solutions to manage heart conditions, the adoption of CRT devices is expected to rise substantially, fostering innovation and investment in this critical market.

Moreover, advancements in CRT technology and device design are anticipated to further boost market growth. The development of next-generation CRT devices with enhanced features, such as remote monitoring capabilities and improved battery life, is enhancing patient outcomes and convenience. Additionally, the growing emphasis on personalized medicine and patient-centered care is driving the demand for CRT devices that can be tailored to individual patient needs. As the healthcare landscape continues to evolve, the market for cardiac resynchronization therapy devices is likely to witness a surge in demand for innovative solutions that improve patient care and quality of life.

In addition, the increasing focus on regulatory compliance and clinical evidence is expected to shape the future of the CRT devices market. As regulatory bodies implement stricter guidelines for device approval and monitoring, the demand for CRT devices that meet these standards will continue to rise. Collaborative efforts between device manufacturers, healthcare providers, and regulatory agencies will be essential in driving these advancements, ensuring that the cardiac resynchronization therapy devices market remains at the forefront of cardiovascular innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• CRT-Defibrillator
• CRT-Pacemaker

By End-use

• Hospital
• Cardiac Center
• Others

COMPANIES PROFILED

• Medtronic, Abbott, Boston Scientific Corporation, Biotronik SE Co KG, MicroPort Scientific Corporation, LivaNova plc, Asahi Kasei Medical Co, Ltd, Nihon Kohden Corporation, Schiller AG, Medico SpA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. CRT-Defibrillator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. CRT-Pacemaker Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End-use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End-use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End-use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End-use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End-use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic
  • 8.2.2 Abbott
  • 8.2.3 Boston Scientific Corporation
  • 8.2.4 Biotronik SE & Co. KG
  • 8.2.5 MicroPort Scientific Corporation
  • 8.2.6 LivaNova Plc
  • 8.2.7 Asahi Kasei Medical Co.Ltd
  • 8.2.8 Nihon Kohden Corporation
  • 8.2.9 Schiller AG
  • 8.2.10 Medico S.P.A